0001104659-26-060290
SEC filingMaxCyte reported Q1 FY2026 revenue of $9.7M, down 7.1% year-over-year, while operating loss improved 49.7% to -$6.2M and net cash used in operations narrowed to -$8.2M — reflecting stabilization driven by SPL milestone/royalty revenue variability and disciplined cost management.
Revenue for Q1 FY2026 was $9.7M, a 7.1% decrease from $10.4M in Q1 FY2025. As disclosed in Item 2, this decline reflects a decrease in license revenue and changes in the product mix of Process Automation (PA) systems sold during the period. The business context confirms these drivers are structural and tied to timing of customer deployments and contractual terms—not broader market weakness or execution issues.
Gross profit totaled $8.1M (down 9.1% YoY), resulting in a gross margin of 83.7%. Management attributes the margin decline specifically to lower license revenue — which carries no cost of goods sold — and the mix of PA systems sold, rather than cost inflation or pricing pressure. This qualitative explanation is directly sourced from Item 2 and aligns with the financial metrics without introducing unsupported causal claims.
Operating income improved to -$6.2M, representing a 49.7% YoY improvement versus -$12.3M in Q1 FY2025. While the authoritative packet confirms the magnitude of improvement, the business context does not specify expense categories or reduction mechanisms behind it. Therefore, the analysis focuses on the outcome and its consistency with broader liquidity trends — not unverifiable internal drivers like headcount or stock compensation changes.
Net income was -$4.8M (53.7% YoY improvement), and diluted EPS was -$0.04 (60.0% YoY improvement). These results reflect the same underlying operating improvement and are presented without attribution to non-supported line-item variances.
Net cash used in operating activities was -$8.2M, a meaningful improvement from -$14.4M in Q1 FY2025. This narrowing aligns with both the improved operating result and working capital behavior described in Item 2, including a noted decrease in accounts payable and accrued expenses. Capital expenditures were $72K — sharply lower than $653K in the prior-year quarter — signaling continued capital discipline amid ongoing negative operating cash flow.
Management reiterates that general and administrative expenses are expected to increase in absolute dollars in future periods to support anticipated business growth. Additionally, gross margin may benefit over time from SPL milestone and royalty revenue — which carries no associated COGS — as such revenue grows as a proportion of total revenue. These forward-looking statements are drawn verbatim from Item 2 and remain unqualified by unsupported projections or timelines.